Ramos-Silva Alberto, Tavares-Carreón Faviola, Figueroa Mario, De la Torre-Zavala Susana, Gastelum-Arellanez Argel, Rodríguez-García Aída, Galán-Wong Luis J, Avilés-Arnaut Hamlet
Instituto de Biotecnología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, Avenida Universidad S/N, Ciudad Universitaria, CP 66455, San Nicolás de los Garza, NL, Mexico.
Facultad de Química, Departamento de Farmacia, Universidad Nacional Autónoma de México, CP 04510, Ciudad de México, Mexico.
BMC Complement Altern Med. 2017 May 2;17(1):241. doi: 10.1186/s12906-017-1727-y.
Thevetia peruviana (Pers.) K. Schum or Cascabela peruviana (L.) Lippold (commonly known as ayoyote, codo de fraile, lucky nut, or yellow oleander), native to Mexico and Central America, is a medicinal plant used traditionally to cure diseases like ulcers, scabies, hemorrhoids and dissolve tumors. The purpose of this study was to evaluate the cytotoxic, antiproliferative and apoptotic activity of methanolic extract of T. peruviana fruits on human cancer cell lines.
The cytotoxic activity of T. peruviana methanolic extract was carried out on human breast, colorectal, prostate and lung cancer cell lines and non-tumorigenic control cells (fibroblast and Vero), using the MTT assay. For proliferation and motility, clonogenic and wound-healing assays were performed. Morphological alterations were monitored by trypan blue exclusion, as well as DNA fragmentation and AO/EB double staining was performed to evaluate apoptosis. The extract was separated using flash chromatography, and the resulting fractions were evaluated on colorectal cancer cells for their cytotoxic activity. The active fractions were further analyzed through mass spectrometry.
The T. peruviana methanolic extract exhibited cytotoxic activity on four human cancer cell lines: prostate, breast, colorectal and lung, with values of IC 1.91 ± 0.76, 5.78 ± 2.12, 6.30 ± 4.45 and 12.04 ± 3.43 μg/mL, respectively. The extract caused a significant reduction of cell motility and colony formation on all evaluated cancer cell lines. In addition, morphological examination displayed cell size reduction, membrane blebbing and detachment of cells, compared to non-treated cancer cell lines. The T. peruviana extract induced apoptotic cell death, which was confirmed by DNA fragmentation and AO/EB double staining. Fractions 4 and 5 showed the most effective cytotoxic activity and their MS analysis revealed the presence of the secondary metabolites: thevetiaflavone and cardiac glycosides.
T. peruviana extract has potential as natural anti-cancer product with critical effects in the proliferation, motility, and adhesion of human breast and colorectal cancer cells, and apoptosis induction in human prostate and lung cancer cell lines, with minimal effects on non-tumorigenic cell lines.
黄花夹竹桃(Thevetia peruviana (Pers.) K. Schum 或 Cascabela peruviana (L.) Lippold,俗称阿约约特、修士之肘、幸运果或黄夹竹桃)原产于墨西哥和中美洲,是一种传统上用于治疗溃疡、疥疮、痔疮和溶解肿瘤等疾病的药用植物。本研究的目的是评估黄花夹竹桃果实甲醇提取物对人癌细胞系的细胞毒性、抗增殖和凋亡活性。
使用MTT法对黄花夹竹桃甲醇提取物在人乳腺癌、结直肠癌、前列腺癌和肺癌细胞系以及非致瘤对照细胞(成纤维细胞和Vero细胞)上进行细胞毒性活性检测。对于增殖和迁移,进行了克隆形成和伤口愈合试验。通过台盼蓝排斥法监测形态学改变,并进行DNA片段化和AO/EB双重染色以评估细胞凋亡。使用快速色谱法分离提取物,并对所得馏分在结直肠癌细胞上进行细胞毒性活性评估。通过质谱对活性馏分进行进一步分析。
黄花夹竹桃甲醇提取物对四种人癌细胞系:前列腺癌、乳腺癌、结直肠癌和肺癌表现出细胞毒性活性,IC50值分别为1.91±0.76、5.78±2.12、6.30±4.45和12.04±3.43μg/mL。该提取物导致所有评估的癌细胞系的细胞迁移和集落形成显著减少。此外,与未处理的癌细胞系相比,形态学检查显示细胞大小减小、细胞膜起泡和细胞脱离。黄花夹竹桃提取物诱导细胞凋亡死亡,这通过DNA片段化和AO/EB双重染色得到证实。馏分4和5显示出最有效的细胞毒性活性,其质谱分析揭示了次生代谢产物:黄花夹竹桃黄酮和强心苷的存在。
黄花夹竹桃提取物具有作为天然抗癌产品的潜力,对人乳腺癌和结直肠癌细胞的增殖、迁移和黏附以及人前列腺癌和肺癌细胞系的凋亡诱导具有关键作用,对非致瘤细胞系的影响最小。